Related Experiment Videos
Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants
G Opelz1, J Mytilineos, S Scherer
1Transplant Laboratory, Universities of Heidelberg, Germany.
Insights
DNA typing for human leukocyte antigen (HLA) matching significantly improves kidney transplant survival. This method is clinically relevant, outperforming traditional serological typing for predicting graft outcomes.
Area of Science:
- Immunogenetics
- Transplantation immunology
Background:
- Human leukocyte antigen (HLA) matching is crucial for kidney transplant success.
- Traditional serological typing methods may have limitations in accurately assessing HLA compatibility.
Purpose of the Study:
- To evaluate the clinical relevance of DNA-based typing for HLA-DR matching in cadaver kidney transplantation.
- To compare the impact of DNA typing versus serological typing on one-year graft survival.
Main Methods:
- Retrospective analysis of 3455 cadaver kidney transplants.
- HLA-DR typing performed using DNA-RFLP method.
- Comparison of graft outcomes based on HLA-DR matching from DNA and serological typing.
Main Results:
- HLA-DR matching using DNA typing significantly improved one-year graft survival (P < 0.01).
- In cases with discrepant typing results, DNA typing showed a significant impact on graft outcome (P = 0.03), while serological typing did not.
- No association was found between HLA-DR6 or DRB1*1302 and poor graft survival.
Conclusions:
- DNA typing for HLA-DR matching is clinically relevant and superior to serological typing for predicting kidney transplant outcomes.
- The findings support the adoption of DNA typing in clinical transplantation for improved graft survival.
Abstract:
The effect of matching for HLA-DR antigens was analyzed retrospectively in 3455 cadaver kidney transplants that were typed by the DNA-RFLP method. HLA-DR matching improved the one-year graft survival rate significantly (P < 0.01). Importantly, in 718 first transplants in which the number of mismatches assigned by serological typing was different from that assigned by DNA typing, only the DNA results showed a significant impact of matching on graft outcome (P = 0.03). These results demonstrate that DNA typing is clinically relevant. We were unable to confirm that the HLA-DR6 specificity or the DR6-split DRB1*1302 are associated with poor graft survival.